Notice: This company has been marked as potentially delisted and may not be actively trading. Stellar Biotechnologies (SBOT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends SBOT vs. ALMS, MBX, CMRX, OLMA, IRWD, CRVS, TRVI, KRRO, TNGX, and ATAIShould you be buying Stellar Biotechnologies stock or one of its competitors? The main competitors of Stellar Biotechnologies include Alumis (ALMS), MBX Biosciences (MBX), Chimerix (CMRX), Olema Pharmaceuticals (OLMA), Ironwood Pharmaceuticals (IRWD), Corvus Pharmaceuticals (CRVS), Trevi Therapeutics (TRVI), Korro Bio (KRRO), Tango Therapeutics (TNGX), and Atai Life Sciences (ATAI). These companies are all part of the "medical" sector. Stellar Biotechnologies vs. Alumis MBX Biosciences Chimerix Olema Pharmaceuticals Ironwood Pharmaceuticals Corvus Pharmaceuticals Trevi Therapeutics Korro Bio Tango Therapeutics Atai Life Sciences Stellar Biotechnologies (NASDAQ:SBOT) and Alumis (NASDAQ:ALMS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, community ranking, risk, media sentiment, profitability, dividends, earnings and analyst recommendations. Do insiders & institutionals have more ownership in SBOT or ALMS? 1.7% of Stellar Biotechnologies shares are held by institutional investors. 7.8% of Stellar Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher valuation and earnings, SBOT or ALMS? Alumis has lower revenue, but higher earnings than Stellar Biotechnologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStellar Biotechnologies$210K478.18-$5.03M-$1.76-10.70AlumisN/AN/AN/AN/AN/A Do analysts prefer SBOT or ALMS? Alumis has a consensus target price of $26.57, indicating a potential upside of 430.37%. Given Alumis' stronger consensus rating and higher probable upside, analysts clearly believe Alumis is more favorable than Stellar Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stellar Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Alumis 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Does the MarketBeat Community prefer SBOT or ALMS? Stellar Biotechnologies received 219 more outperform votes than Alumis when rated by MarketBeat users. However, 100.00% of users gave Alumis an outperform vote while only 66.48% of users gave Stellar Biotechnologies an outperform vote. CompanyUnderperformOutperformStellar BiotechnologiesOutperform Votes23466.48% Underperform Votes11833.52% AlumisOutperform Votes15100.00% Underperform VotesNo Votes Is SBOT or ALMS more profitable? Alumis has a net margin of 0.00% compared to Stellar Biotechnologies' net margin of -1,782.64%. Alumis' return on equity of 0.00% beat Stellar Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Stellar Biotechnologies-1,782.64% -51.12% -48.37% Alumis N/A N/A N/A Does the media refer more to SBOT or ALMS? In the previous week, Alumis had 30 more articles in the media than Stellar Biotechnologies. MarketBeat recorded 30 mentions for Alumis and 0 mentions for Stellar Biotechnologies. Alumis' average media sentiment score of 0.51 beat Stellar Biotechnologies' score of 0.00 indicating that Alumis is being referred to more favorably in the news media. Company Overall Sentiment Stellar Biotechnologies Neutral Alumis Positive SummaryAlumis beats Stellar Biotechnologies on 10 of the 14 factors compared between the two stocks. Get Stellar Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBOT vs. The Competition Export to ExcelMetricStellar BiotechnologiesPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$100.42M$6.99B$5.74B$9.09BDividend YieldN/A2.91%5.28%4.00%P/E Ratio-10.705.1565.9415.98Price / Sales478.18332.101,004.6779.02Price / CashN/A75.4646.0638.87Price / Book8.895.535.074.99Net Income-$5.03M$123.50M$113.48M$222.61M Stellar Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBOTStellar BiotechnologiesN/A$18.84-10.7%N/A+336.9%$100.42M$210,000.00-10.7025Gap DownHigh Trading VolumeALMSAlumisN/A$7.44-0.5%$27.57+270.6%N/A$351.32MN/A0.00N/AGap UpMBXMBX Biosciences2.5846 of 5 stars$10.49+4.8%$37.25+255.1%N/A$350.58MN/A0.0036CMRXChimerix3.8231 of 5 stars$3.80-3.6%$8.50+123.7%+368.8%$341.77M$320,000.00-4.0490OLMAOlema Pharmaceuticals1.584 of 5 stars$5.96-2.5%$28.75+382.4%-66.5%$341.51MN/A-2.7270Positive NewsGap DownIRWDIronwood Pharmaceuticals4.1005 of 5 stars$2.10-10.3%$10.67+407.9%-87.7%$336.06M$442.73M-70.00220Gap DownCRVSCorvus Pharmaceuticals2.524 of 5 stars$5.07-5.4%$12.38+144.1%+123.9%$325.80MN/A-5.4530TRVITrevi Therapeutics2.853 of 5 stars$4.22+7.1%$9.31+120.7%+141.5%$324.39MN/A-9.5920Positive NewsKRROKorro Bio1.5175 of 5 stars$33.50-1.8%$144.00+329.9%-46.7%$313.90MN/A0.0070News CoverageTNGXTango Therapeutics3.3168 of 5 stars$2.91-2.3%$13.14+351.6%-79.9%$312.59M$36.53M-2.4790Analyst RevisionATAIAtai Life Sciences2.6559 of 5 stars$1.85+19.4%$9.00+386.5%+28.9%$310.43M$310,000.00-2.2880Gap DownHigh Trading Volume Related Companies and Tools Related Companies ALMS Competitors MBX Competitors CMRX Competitors OLMA Competitors IRWD Competitors CRVS Competitors TRVI Competitors KRRO Competitors TNGX Competitors ATAI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SBOT) was last updated on 2/12/2025 by MarketBeat.com Staff From Our PartnersNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored$589 billion wiped out overnightYou need to watch this before you invest another cent in AI. Because more than $589 billion was wiped out o...Porter & Company | SponsoredYou’ll remember where you were when you saw this…Elon Musk is heavily invested in a cutting-edge new technology. In fact, Musk has turned the new president ...InvestorPlace | SponsoredElon has entered the MarkBeat conversationSpivey's firm accurately warned of both the 2008 and 2020 stock market crashes and have charged institutional ...Altimetry | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stellar Biotechnologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Stellar Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBOT Stock Alerts